OKT3 as prophylaxis immunosuppression in pediatric liver transplant recipients.
Sommerauer
J F
JF
Department of Pediatrics and Surgery, University and Children's Hospital of Western Ontario, London, Canada.
Atkison
P
P
Howard
J
J
Grant
D
D
Wall
W
W
D000293:Adolescent; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007223:Infant; D016031:Liver Transplantation / Q000009:adverse effects / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology*; D016176:T-Lymphocyte Subsets / Q000276:immunology
D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D008775:Methylprednisolone